ARF encoded by the INK4a tumor suppressor gene locus functions upstream of p53 to induce cell cycle arrest. p19 ARF can interact with MDM2 and p53 in cells ectopically overexpressing these three components, but the biochemical cascades from p19 ARF to cell cycle arrest has not been fully elucidated. In this study, we generated stably transfected NIH3T3 cells that express exogenous p19 ARF under the control of a heavy metal-inducible metalothionine promoter. Cells arrested in G1 by ectopically expressed p19 ARF contained considerably reduced G1 cyclin dependent kinase (cdk2 and cdk4) activities. The expression of cyclin A (a regulatory subunit of cdk2) markedly decreased, while cyclin D1, the major cdk4 partner in ®broblasts, expressed at a slightly higher level and formed complexes with cdk2 and cdk6 in addition to cdk4. Induction of p19 ARF activated p53 by increasing its stability, and allowed the expression of p21
Introduction
Two tumor suppressor gene products, the retinoblastoma protein (pRb) and p53, are closely coupled with the machinery regulating the progression of the mammalian cell cycle (for reviews see Weinberg, 1995; Levine, 1997; Sherr, 1996) . pRb exerts its growth suppressive function during G1, and its phosphorylation by G1 cyclin-dependent kinases (cdks) in late G1 neutralizes its eects and allows cells to progress into S phase (Weinberg, 1995; Sherr, 1996) . p53 is expressed at an almost undetectable level in proliferating cells, but once chromosomal DNA is damaged by ionizing irradiation or chemicals, p53 is upregulated and functions as a transcription factor to activate the expression of genes which induce cell cycle arrest or apoptosis (Gottlieb and Oren, 1996; Ko and Prives, 1996; Levine, 1997) . p53 inducible genes include the Cip1 and MDM2 genes. p21
Cip1 belongs to the Cip/ Kip family of cdk inhibitors, which bind to G1 cyclincdk complexes and inhibit their protein kinase activities (Sherr and Roberts, 1995) . The MDM2 gene encodes a protein that binds to and promotes the degradation of p53 (Momand et al., 1992; Haupt et al., 1997; Kubbutat et al., 1997) possibly by acting as a p53 E3 ligase (Honda et al., 1997) , thereby creating a negative feedback loop between p53 and MDM2 allowing the eects of p53 to be temporal.
The recently identi®ed tumor suppressor gene locus, the INK4a gene, encodes two distinct proteins, p16 INK4a and p19 ARF , both of which are capable of arresting cells in G1 phase of the cell cycle (Serrano et al., 1993; Quelle et al., 1995; Haber, 1997) . p16
INK4a and p19 ARF transcripts derive from alternative ®rst exons, E1 a and E1 b, respectively, but share the common exons, E2 and E3 (Mao et al., 1995; Stone et al., 1995; Quelle et al., 1995) . Because the reading frames of these two proteins in E2 and E3 are dierent, p16 INK4a and p19 ARF are entirely distinct polypeptides (Quelle et al., 1995) . p16 INK4a can directly bind to and inhibit the activity of cyclin D-dependent kinases (cdk4 and 6), and arrests pRb-positive cells in G1 by preventing pRb from being phosphorylated (Serrano et al., 1993; Weinberg, 1995; Sherr, 1996; Sherr and Roberts, 1995) . Overexpression of p19 ARF induces not only G1 arrest but also G2 arrest in rodent ®broblasts (Quelle et al., 1995) , but the cells harboring dominant negative p53 or lacking functional p53 are refractory to p19 ARF -mediated cell cycle arrest (Quelle et al., 1995; Kamijo et al., 1997) , suggesting that p19 ARF functions upstream of p53. Deletions and mutations in the INK4a gene are frequently found in a wide variety of human cancers (Hall and Peters, 1996; Hunter and Pines, 1994; Shea and Roberts, 1995; Sherr, 1996) . Many mutations, which reside in E2, functionally inactivate p16
INK4a without aecting the ability of p19 ARF to arrest cell cycle , suggesting that p16
INK4a is a bona ®de tumor suppressor protein in humans. However, E1 b-speci®c knock-out mice develop tumors without aecting expression of p16
INK4a (Kamijo et al., 1997) , indicating that p19
ARF can function as a tumor suppressor protein in mice. Thus, two dierent proteins derived from the INK4a gene locus play important roles in tumor suppression, by independently regulating the activities and functions of pRb and p53 tumor suppressor proteins (Haber, 1997) .
The precise function of p19 ARF remains unknown because it shares no amino acid homology with any known proteins and lacks any decisive functional protein motifs (Quelle, et al., 1995) . However, Pomerantz et al. (1998) and Zhang et al. (1998) In cells transiently transfected with plasmids expressing  p19   ARF   , MDM2, and p53, they form a ternary complex,  and p19 ARF promotes the rapid degradation of MDM2, leading to p53 stabilization and accumulation. In addition, Kamijo et al. (1998) showed that p19 ARF can directly interact with p53 in the absence of MDM2, and modulate the function of p53. However, the behavior of endogenous MDM2 and p53 in cells arrested by p19 ARF has not been fully elucidated and the precise eect of p19 ARF during cell cycle arrest remains to be investigated. In this study, we constructed a cell system where expression of exogenous p19
ARF can be extracellularly controlled, and analysed the eect of p19 ARF on the cell cycle regulators. We found that ectopic expression of p19 ARF predominantly arrested mouse ®broblasts in G1 phase, and that such cells contained markedly reduced G1 cyclin-dependent kinase activities either by prevention of cyclin expression or by induction of p21
Cip1 that tightly associated with and inhibited the activity of G1 cyclin-cdk complexes. p19 ARF formed complexes with several cellular proteins including MDM2, but not p53, resulting in inactivation of MDM2, increase of the p53 stability, and induction of p21
Cip1
.
Results

Construction of the p19
ARF inducible cell system
In order to investigate the action of p19 ARF and its eect on cell cycle progression, we decided to construct a cell system where p19 ARF expression can be extracellularly controlled. We isolated mouse p19 ARF cDNA from lung RNA by RT ± PCR, tagged it with an HA epitope, and inserted it into an inducible expression vector (Cook et al., 1996) containing a heavy metal-inducible metalothionine promoter and a neo gene conferring resistance to G418, and transfected the plasmid into mouse NIH3T3 ®broblasts. After selection in G418, several cell clones (NIH-ARF clones) were isolated and tested for expression of p19 ARF in response to heavy metal. We presented the results obtained from one representative cell line, but several independent clones behaved similarly. HAp19 ARF was detected only in NIH-ARF cells in the presence of heavy metal (Figure 1a) . After 48 h heavy metal treatment, the population of NIH-ARF cells accumulated in G1 phase with a 2n DNA content (Figure 1b) . Because parental NIH3T3 cells did not signi®cantly alter the cell cycle distribution in the presence of heavy metal (Figure 1b ) and the doubling times of NIH3T3 cells were identical in the presence and absence of heavy metal (data not shown), we reasoned that ectopically expressed p19 ARF , but not the toxicity of heavy metal, rendered mouse ®broblasts to arrest in G1.
p19 ARF was ®rst detected 3 h post heavy metal addition, and the levels of the protein gradually increased, reaching a plateau 25 h post heavy metal addition (Figure 1c ). The population of cells in S phase gradually decreased during 48 h after heavy metal addition, and that of cells in G1 phase reciprocally increased (Figure 1d) . We observed only a marginal increase of the number of cells in G2/M phase. Thus, induction of p19 ARF expression arrested proliferating mouse ®broblasts mainly in G1 for 2 days after heavy metal addition. It is interesting that during the ®rst 24 h after metal addition, but not after cells arrested in G1, we observed faster-migrating molecules not detected in control NIH cells (Figure 1c ). The precise identity of the molecules remains unknown, but it is most likely that they represent degradation intermediates. If so, p19 ARF can be post-translationally regulated by a selective and speci®c proteolytic mechanism in proliferating cells. It is reported that in some cases, p19 ARF proteins are undetectable even though p19 ARF -speci®c mRNA is abundantly expressed (Della Valle et al., 1997) . Further analyses are required to elucidate this matter.
Induction of p19
ARF reduces the activities of G1 cyclin-dependent kinases Since induction of p19 ARF mainly arrested ®broblasts in G1, we focused our attention on the eect of p19 ARF on G1 regulators. The activities of G1 cyclin-cdk complexes (cyclin D-cdk4 or 6, and cyclin A and Ecdk2) are absolutely required for cells to progress through G1 and to enter S phase (Sherr, 1996) . Therefore, we examined the G1 cyclin-cdk activities in cells expressing p19
ARF . NIH and NIH-ARF cells were treated with heavy metal for 48 h, and the cdk4 and cdk2 complexes were quantitatively immunoprecipitated from each cell lysate with excess amounts of antibodies speci®cally recognizing each protein and assayed for their kinase activities in vitro using recombinant Rb proteins (for cdk4 kinase) and histone H1 (for cdk2 kinase) as substrate (Figure 2 ). Cdk4-associated kinase activity was very similar between NIH and NIH-ARF cells in the absence of heavy metal, and was not signi®cantly aected in NIH cells by addition of metal. However, NIH-ARF cells treated with metal exhibited only a background level of cdk4 activity (Figure 2a) . Similarly, heavy metal treatment did not aect the cdk2 activity in NIH cells, whereas NIH-ARF cells treated with metal contained markedly reduced levels of cdk2 kinase activity (Figure 2b ). Thus, in cells arrested in G1 by induction of p19 ARF , both of the G1 cyclin-cdk activities were signi®cantly hampered.
To investigate the precise action of p19 ARF on G1 arrest and downregulation of G1 cyclin-cdk kinase activities, we examined the expression levels of various G1 regulatory proteins (Figure 3 ). pRb was highly phosphorylated in proliferating cells and exhibited a slower mobility in SDS polyacrylamide gel electrophoresis, but in cells induced to express p19 ARF , pRb migrated faster, indicating the hypophosphorylation of the protein, which con®rms that G1 cyclin-cdk activities were de®nitely downregulated within living cells. The expression level of cdk2 was not altered, but that of cyclin A (and cyclin E as well, data not shown) was markedly reduced, which indicates that downregulation of the cdk2 activity was mostly due to the loss of its regulatory subunit. By contrast, the expression of cdk4 was not downregulated, and the level of cyclin D1, the major D-type cyclin in ®broblasts (Quelle et al., 1993; Sherr, 1996; Matsushime et al., 1994) , was even higher compared with that of control cells. This could mean that cyclin D1 was one of the targets of p19 ARF , or most likely that p19 ARF induced cell cycle arrest in mid G1, where the activity of cyclin D-cdk kinase is required (Quelle et al., 1993) and the level of cyclin D1 is slightly higher than that in other phases of the ®broblast cell cycle (Matsushime et al., 1991) . The tumor suppressor protein, p53, and the product of its target gene, p21 Cip1 (Sherr and Roberts, 1995) , were highly induced in p19 ARF -expressing cells, which suggests that cyclin D-cdk4 kinase, as well as the remaining small amount of cyclin A and E-cdk2 complexes, was inhibited by cdk inhibitor, p21
Cip1 (see below). In addition, it is worth noting that the expression level of the cdc2 subunit was signi®cantly reduced, which might aect the progression of G2/M phase, because the activity of cyclin B-cdc2 is absolutely required for G2/M progression (Dunphy, 1994; King et al., 1994) . Furthermore, p27
Kip1 was markedly downregulated by p19 ARF . We do not know the mechanism and the physiological signi®cance of p27
Kip1 downregulation at the present moment. Thus, induction of p19 ARF inhibited cell cycle progression by altering the expression levels of various cell cycle regulators and downregulates cdk2 and cdk4 activities through dierent mechanisms.
Induction of p19 ARF alters subunit organization of cyclin D-cdk complexes
The expression of p19 ARF did not inhibit the expression of cyclin D1 and cdk4 subunits. We, therefore, examined the formation of cyclin D1-cdk complexes in cells expressing p19
ARF . NIH and NIH-ARF cells were incubated in the presence and absence of heavy metal for 48 h. Cyclin D1 and cdks (cdk4, 6, and 2, or cdc2) were quantitatively immunoprecipitated from each cell lysate with excess antibodies speci®cally recognizing each protein, separated by SDS-polyacrylamide gel electrophoresis, and blotted with antibodies recognizing each cdk subunit ( Figure 4 ). The amount of cdk4, the major cyclin D1 partner in ®broblasts, in anti-cyclin D1 immunoprecipitates slightly increased. The cyclin D1-cdk4 is the major D-type cyclin-cdk complex in ®broblasts, and the interaction between cyclin D1 and cdk2 or 6 was almost undetectable in proliferating cells. However, in cells arrested by p19 ARF , signi®cant amounts of cdk2 and 6, but not cdc2, were found in association with cyclin D1. Thus, in cells induced to express p19 ARF , cyclin D1 formed complexes with all of the possible cdk partners (Cdc2 has never been reported to form a complex with cyclin D1). This is partly because induction of p19 ARF elevated the levels of cyclin D1 expression (Figure 3 ), which enabled most of the cdks to associate with the cyclin D1 regulatory subunits. Or, alternatively, p21
Cip1 induced by p19 ARF stabilized all of the cyclin D1-cdk complexes (Labaer et al., 1997 , and see below).
p21
Cip1 induced by p19 ARF is associated with cyclin D-cdk complexes
Induction of p19
ARF downregulated the cdk4 activity ( Figure 2) . However, the expression of both cyclin D1 , but not that of p27 Kip1 , was elevated ( Figure 3) . Therefore, we addressed whether inhibition of cdk4 activity was due to the increased binding of p21
Cip1 to the cyclin D-cdk complexes. The lysate extracted from cells induced to express p19 ARF was quantitatively immunoprecipitated with excess amounts of various antibodies and analysed by immunoblotting using antibody speci®cally recognizing murine p21 Cip1 ( Figure 5 ). As expected, anti-cyclin D1 immunoprecipitates contained a large amount of p21 Cip1 . All of the cdks that formed complexes with cyclin D1 under these conditions (cdk2, 4, and 6) interacted with p21
Cip1
, while cdc2, which failed to bind to cyclin D1, did not (Figure 5a ). The amounts of p21 Cip1 bound to each cdk subunit seemed to be proportional to those of cdks associated with cyclin D1, and the sum total of p21 Cip1 bound to cdk2, 4, and 6 was approximately equal to the cyclin D1-bound p21 Cip1 . p21
Cip1 was found in complexes with G1 cyclin subunits (Figure 5b ) in proportion to their expression levels (NIH3T3 ®broblasts express cyclin D1 and D2, but almost undetectable levels of cyclin D3, data not shown, but see Quelle et al., 1993;  
p19
ARF interacts with MDM2, but not with p53
We showed that p21 Cip1 played an important role in p19 ARF -mediated inhibition of G1 cyclin-cdk activities in association with G1 arrest. Induction of p21
Cip1
Figure 2 G1 cyclin-dependent kinase activities are downregulated in cells induced to express p19 ARF . NIH and NIH-ARF cells were treated with and without ZnSO 4 for 48 h, and the lysates from the same number of cells (10 7 cells) were quantitatively immunoprecipitated with excess amounts of antibodies speci®cally recognizing cdk4 (a) and cdk2 (b). The immunoprecipitates containing cyclin-cdk complexes were assayed for their kinase activities in vitro using recombinant Rb proteins (a) and histone H1 (b) as substrate. Quantitative analysis of the data using a Fuji BAS-2000 image analyzer is also shown. The background levels of kinase activities contained in immunoprecipitates using irrelevant antibodies in each case were set to 10.0 relative cdk4 or cdk2 kinase activities. The results are representative of two independent experiments ARF binds to MDM2 and inhibits G1 cyclin-cdk kinases K Kurokawa et al appears to be mediated by p53 because the levels of p53 expression were upregulated in cells expressing p19 ARF (Figure 3) , and the Cip1 gene is one of the p53 inducible genes (Sherr and Roberts, 1995; Levine, 1997) . To investigate the molecular role of p19 ARF in p53 activation, we examined the cellular proteins with which p19 ARF interacts. NIH-ARF cells were incubated with and without heavy metal for 48 h, and metabolically labeled with 35 S-methionine. The complexes containing HA-tagged p19 ARF were immunoprecipitated from the labeled cell lysates with antibody recognizing an HA-epitope and separated by SDSpolyacrylamide gel electrophoresis. Figure 6a shows that p19 ARF formed complexes with several cellular proteins whose apparent molecular weights were 120, 110, 90 (doublets), 65, 60, 56, 54, and 35 kDa. Because p19 ARF seems to function upstream of p53 and the molecular weights of some interacting proteins (p56, p54 and p90) appear to be close to those of p53 and its regulator, MDM2, we tested whether p53 and MDM2 interacted with p19
ARF . First of all, we immunoprecipitated HA-p19 ARF , p53, and MDM2 from the metabolically-labeled lysates with antibodies speci®c to each of them, and compared their mobility on SDSpolyacrylamide gel electrophoresis. Figure 6b shows that the doublet bands around p90 in p19 ARF -immunoprecipitates exhibited a mobility very similar to that of MDM2. We found a 54 kDa protein migrating much slower than p53 in MDM2 immunoprecipitates, whose mobility on SDS-polyacrylamide gel electrophoresis was exactly the same as that of p19 ARF -associated p54 (indicated by an arrow in Figure  6b ). We do not yet know whether this protein is p54 itself or not because speci®c antibody is not available at the present moment. However, these results clearly indicated that p54 and p56 were dierent from p53 in molecular sizes on SDS-polyacrylamide gel electrophoresis. Note that the apparent dierence of p19 ARFassociated proteins in Figure 6 panels a and b is due to the dierent labeling times (24 h and 15 min for panels a and b, respectively). We performed several independent experiments with dierent labeling times, all of which indicated that p90 exhibited identical mobility with mouse MDM2 and that p53 migrated faster than p54 and p56. Only representative results, in which p90 and MDM2 were well labeled, are shown in Figure 6b . The intensity of 35 S-labeled p19 ARF in anti-MDM2 immunoprecipitates is not strong in Figure 6b . This is because 15 min labeling was not long enough to maximally label p19 ARF in MDM2 complexes and only a portion of p19 ARF molecules formed a complex with MDM2.
The lysates from unlabeled cells treated with and without heavy metal were quantitatively immunoprecipitated with excess amounts of anti-HA antibody and analysed by immunoblotting using antibodies specifically recognizing mouse p53 and MDM2. In cells Figure 4 p19 ARF enhances the complex formation between cyclin D1 and cdks. NIH and NIH-ARF cells were treated with and without ZnSO 4 for 48 h, and the lysates from the same number of cells (10 6 cells) were quantitatively immunoprecipitated with excess amounts of antibodies speci®cally recognizing cyclin D1 (a-cycD1) and cdks (a-cdks; cdk4, 6, 2, and cdc2, respectively). The immunoprecipitates were separated by SDS-polyacrylamide gel electrophoresis, and analysed by immunoblotting using antibodies speci®cally recognizing each cdk. The results are representative of two independent experiments. In the bottom panel, downregulation of cdc2 in NIH-ARF cells in the presence of ZnSO 4 is not apparently striking. This is because the ®lm was overexposed in order to show that cdc2 was not detected in anticyclin D1 immunoprecipitates. Quantitative analysis of the membrane using a Densitograph/Lumino-CCD (ATTO) revealed that cdc2 was downregulated in heavy metal-treated NIH-ARF cells Under these conditions more than 80% of cyclin D-cdk complexes were recovered. (c) The complexes containing cyclin D1 and cdc2 were isolated by quantitative immunoprecipitation from the lysates of NIH and NIH-ARF cells with and without ZnSO 4 treatment, and were subjected to immunoblotting analysis using antibody to p21
. The results are representative of two independent experiments p19 ARF binds to MDM2 and inhibits G1 cyclin-cdk kinases K Kurokawa et al induced to express p19 ARF , the level of p53 protein increased, but not a trace of the protein was detected in anti-HA immunoprecipitates (Figure 6c ). The expression of MDM2 proteins was upregulated in these cells, consistent with the fact that the MDM2 gene is one of the p53 inducible genes, and in contrast with p53, most of the MDM2 proteins were recovered in the complex with p19 ARF (Figure 6d , note that only 20% of the lysate was loaded in lanes for`Direct lysates'). In reciprocal experiments, anti-MDM2 immunoprecipi- S-methionine for 15 min, and the cell lysates were immunoprecipitated with excess amounts of antibodies speci®c to an HAepitope (a-HA), p53 (a-p53), and MDM2 (a-MDM2), and analysed as in a. The positions of MDM2, p53, and HA-p19 ARF are indicated on the right. The arrow indicates the position of a 54 kDa protein found in MDM2 immunoprecipitates, whose mobility is exactly the same as that of p19 ARF -associated p54 (see text). (c) The lysates (Direct lysates) and anti-HA immunoprecipitates (a-HA) of the lysates from unlabeled NIH and NIH-ARF cells treated with ZnSO 4 were analysed by immunoblotting using antibody speci®c to p53. Anti-HA immunoprecipitates contained more than 80% of HA-p19 ARF expressed in the cells. (d and e) The lysates from unlabeled NIH and NIH-ARF cells treated with and without ZnSO 4 were quantitatively immunprecipitated with excess amounts of antibodies indicated on the top (NRS; normal rabbit serum), and analysed by immunoblotting with antibodies to MDM2 (d) and with anti-HA antibody (e). As a control, the results of the analysis using lysates without immunoprecipitation (Direct lysates) are included. Note that 20% of the lysates used for immunoprecipitation were loaded in lanes for`Direct lysates'. To speci®cally determine the position of MDM2, mouse MDM2 transcribed and translated in vitro (IVT) was also used in d. Experiments were done at least twice with similar results and representative data are shown p19 ARF binds to MDM2 and inhibits G1 cyclin-cdk kinases K Kurokawa et al tates contained only a portion of p19 ARF (Figure 6e ). Taken together, p19
ARF interacted with a set of the cellular proteins including MDM2, but not p53, and the majority of MDM2 was sequestered into the complex with p19 ARF and seemed to be unable to bind to and inactivate p53. In fact, we found increased amounts of MDM2-unbound p53 in p19 ARF expressing cells (data not shown). This would, at least in part, account for the mechanism of p19 ARF -mediated activation of p53 and subsequent induction of p21 Cip1 . However, our results do not preclude the possibility that other pathways triggered by p19 ARF may collaboratively participate in inhibition of G1 cyclincdk activities and the cell cycle arrest in G1.
p19
ARF expression markedly increases the stability of p53, and slightly decreases that of MDM2 MDM2 functions to negatively regulate the activity of p53 by directly binding to it and promoting its degradation (Momand et al., 1992; Haupt et al., 1997; Kubbutat et al., 1997; Honda et al., 1997) . Since we found that most of the MDM2 were sequestered by p19 ARF , we addressed whether the half life of p53 increased in cells expressing p19 ARF , and examined whether the stability of MDM2 may also be altered. NIH and NIH-ARF cells were incubated with heavy metal for 48 h, pulse labeled with 35 S-methionine, and chased in the presence of excess cold methionine. Metabolically labeled p53 and MDM2 were recovered by quantitative immunoprecipitation using excess amounts of antibodies speci®c to each of them, and the relative [ (Figure 7) . In proliferating ®broblasts, p53 was rapidly degraded with a half life of ca 20 min, while in cells expressing p19 ARF , p53 was very stable (more than 90 min of half life). Interestingly, the stability of MDM2 was also aected, although the eect was not so striking as that on p53. MDM2 in control NIH cells was relatively stable although its expression level was low, but p19 ARF expression rendered it unstable. Thus, p19 ARF binds to MDM2, sequestering it from p53 and promoting its degradation, which reciprocally increases the stability and the expression levels of p53.
Discussion
The INK4a tumor suppressor gene locus encodes two distinct proteins, p16
INK4a and p19 ARF (Serrano et al., 1993; Quelle et al., 1995) . p16
INK4a functions as a stoichiometric inhibitor of cyclin D-dependent kinases, and arrests cells only in G1 (Serrano et al., 1993; Weinberg, 1995; Sherr, 1996; Sherr and Roberts, 1995) . p19 ARF functions upstream of p53, and induces both G1 and G2 arrest (Quelle et al., 1995) . Although the precise function of p19 ARF remains unknown, recent reports suggest that p19 ARF can associate with MDM2 in vivo and inhibit its function (Pomerantz et al., 1998; Zhang et al., 1998) , or that it can directly interact with and modulate the function of p53 (Kamijo et al., 1998) . However, the experiments were mainly performed using cells transiently transfected with plasmids expressing p19 ARF , MDM2, and p53, and analyses of the endogenous proteins during cell cycle arrest induced by p19 ARF are necessary to fully elucidate the matter. To investigate this point, we constructed a cell system where p19 ARF expression can be controlled by addition of heavy metal into medium. Under the ARF binds to MDM2 and inhibits G1 cyclin-cdk kinases K Kurokawa et al conditions we used, no toxicity of heavy metal was observed, allowing us to examine the eect of p19 ARF expression on the cell cycle progression and the action of endogenous cell cycle regulators. Although p19 ARF is capable of arresting cells in both G1 and G2, induction of p19 ARF arrested proliferating mouse ®broblasts predominantly in G1. It could be that more cells are eligible to arrest in G1 among a mixed population of growing cells (e.g., more cells are in G1 than in G2 when p19 ARF is expressed), or that p19 ARF needs to express at a higher level to arrest cells in G2 rather than in G1. Although Quelle et al. (1995) originally reported that p19 ARF can induce both G1 and G2 arrest, the eect of p19 ARF on G2/M phase is marginal in normally proliferating cells and best seen in cells engineered to overexpress cyclin D1 (Quelle et al., 1995) , suggesting that increased amounts of cyclin D1-cdk4 complexes sequester p21
Cip1 and render cells partially resistant to G1 arrest without aecting p53-regulated inhibitors of G2/M progression such as 14-3-3s (Hermeking et al., 1997) . Our ®ndings are totally consistent with their results. However, we did not observe the morphological alterations that they did (Quelle et al., 1995) . Cells arrested by ectopic expression of p19 ARF were neither rounded nor refractile, and they look normal and are adherent (unpublished observation). This dierence could be due to the dierent ways the protein is expressed. Generally, retrovirus-mediated gene transfer, which they used, allows cells to express a very high levels of the proteins, while the metalothionine promoter we used in this study is not necessarily a strong one and appears to induce a minimum level of p19 ARF sucient to arrest the cell cycle.
Both of the G1 cyclin-dependent kinase (cdk2 and cdk4) activities were markedly downregulated in cells induced to express p19 ARF . The expression of the cdk2 subunit (cyclin A) was signi®cantly decreased and the remaining small amount of cyclin E-cdk2 complexes was associated with and inhibited by p21 Cip1 . In contrast, the major regulatory subunit of cdk4 in ®broblasts, cyclin D1 (Quelle et al., 1993; Sherr, 1996; Matsushime et al., 1994) , expressed at slightly higher levels than in normally proliferating cells. The expression of cyclin D1 is not strictly cell cycle dependent, but it does¯uctuate during the cell cycle with a peak in mid G1 (Matsushime et al., 1991) . Thus, the low levels of cyclin A expression and the slight increase of cyclin D1 expression seem to re¯ect that the cells were arrested in mid G1, where cyclin D1-cdk4 executes its function (Quelle et al., 1993) and the expression of cyclin A is low. Although D-type cyclins are capable of interacting with cdk2, 4, 5, and 6, cyclin D1 predominantly forms a complex with cdk4 in proliferating ®broblasts and macrophages (Sherr, 1996; Matsushime et al., 1991) . In asynchronous populations of NIH ®broblasts, we found a large amount of cyclin D1-cdk4 complexes, but failed to detect the interaction between cyclin D1 and other cdks (cdk2 and 6). Surprisingly, in cells expressing p19 ARF , cdk2 and cdk6 were co-immunoprecipitated with cyclin D1, and all of the cyclin D1-cdk complexes contained p21
Cip1
. These results suggest that p21
Cip1 stabilized the cyclin D-cdk complexes and/or rendered free subunits to form complexes. Such activity of p21 Both Pomerantz et al. (1998) and Zhang et al. (1998) reported that p19 ARF can associate with MDM2 without interfering with MDM2-p53 interaction and can form a ternary complex with MDM2 and p53 in cells engineered to overexpress all three components. Kamijo et al. (1998) showed that p19 ARF can directly interact with p53 in the absence of MDM2. However, in cells arrested by p19 ARF , we found that p19 ARF formed a complex with MDM2, but not with p53. These discrepancies may simply represent the dierent stability of each complex in a dierent setting. However, a very high levels of MDM2 are expressed in p19 ARF -expressing cells (Pomerantz et al., 1998; Zhang et al., 1998; Kamijo et al., 1998; and this study) , in spite of the fact that the half life of MDM2 declines in some cases (Pomerantz et al., 1998; Zhang et al., 1998 ; and modestly in this study). Therefore, it is not the downregulation of MDM2 proteins but the binding of p19 ARF to MDM2 or p53 per se that increases the stability of and activates p53. Since our results showed that p19 ARF was associated with most of MDM2 without forming the complex with p53, we propose that p19 ARF sequesters MDM2 and prevents it from binding to p53. Alternative interpretation is that p19 ARF -MDM2 complex creates p53-independent signals to inhibit cell proliferation (see below).
The main function of MDM2 seems to negatively regulate p53 (Montes de Oca Luna et al., 1995; Jones et al., 1995; Levine, 1997) , but other functions of MDM2 have been recently suggested (Piette et al., 1997) . Besides p53, MDM2 can interact with pRb (Xiao et al., 1995) , the transcription factors E2F-1/DP-1 (Martin et al., 1995) , ribosomal L5 protein (Marechal et al., 1994) , and TATA-binding protein (Leng et al., 1995) . Although p19 ARF requires wild-type p53 to arrest cell cycle (Quelle et al., 1993; Kamijo et al., 1997) , binding of p19 ARF may aect the formation or the function of the complexes between MDM2 and the proteins described above. In addition, Brown et al. (1998) showed that MDM2 can induce G1 arrest through domains outside of the p53-interacting regions. Interestingly, the cell cycle-inhibitory domains of MDM2 (amino acid residues 155 ± 220, and 270 ± 324; Brown et al., 1998) partially overlap with the regions required for interaction with p19 ARF (amino acid residues 155 ± 220, and somewhere in the Cterminus; Pomerantz et al., 1998) . Thus, it is possible that the complex formation between p19 ARF and MDM2 activates the p53-independent signaling pathway. In this scenario, p53 is required only for induction of MDM2 but not thereafter, but our results suggest that p21 Cip1 , which is induced by p53, plays an important role in inhibition of G1 cyclin-cdk activities. Therefore, both p53-dependent and -independent signals may collaboratively function to induce G1 arrest.
In addition to activation of the p53-mediated pathway, we reproducibly observed the downregulation of cdc2 and p27
Kip1 in cells induced to express p19 ARF (Figure 3 ). The precise mechanism and the physiological signi®cance of this phenomenon remain unknown at the present moment, but this may imply that p19
ARF induces factors or activates pathways in p19 ARF binds to MDM2 and inhibits G1 cyclin-cdk kinases K Kurokawa et al which p53 is not involved. p19
ARF interacted with several cellular proteins other than MDM2 (Figure 6a ). Identi®cation and characterization of such interacting molecules may reveal such unknown factors or pathways. Our NIH-ARF inducible cell system would be a very useful tool with which to further investigate the p19 ARF -activated pathways and the precise role of MDM2 played in p19 ARF -mediated cell cycle arrest.
Materials and methods
Vector construction
Total RNA was prepared from lung excised from mice using Isogen (Nippon Gene), and cDNA was synthesized from 1 mg of RNA template with random oligo primers and Avian Myeloblastosis Virus reverse transcriptase using a Takara RNA LA PCR Kit (AMV) according to the manufacturer's instructions. PCR ampli®cation of mouse p19 ARF transcripts was performed with oligonucleotide primers (5'-CAT-ATGGGTCGCAGGTTCTTGG-3' and 5'-GGATCCGTG-CTTGAGCTGAAGCTATG-3') speci®c for coding sequences of p19 ARF (sequences of sense primer were chosen from those in exon 1b and contain initial ATG, and sequences of antisense primer were from exon 2 and contain stop codon; Quelle et al., 1995) with 40 cycles of denaturation (948C, 1 min), annealing (568C, 1 min), and extension (728C, 2 min). After cloning into the pGEM-T plasmid (Promega), both strands of p19 ARF fragments were sequenced to con®rm sequence integrity. The entire coding sequence of mouse p19 ARF was linked in frame with a DNA fragment containing the initial methionine codon and the coding sequences of an HA epitope (YPYDVPDYASLGGP) (a gift from Dr Fujisawa) and inserted into the expression vector (pMT-CB6+) containing a sheep metallothionein promoter and a neo gene (Cook et al., 1996) .
Cell culture, transfection, and cell cycle analysis Mouse NIH3T3 ®broblasts were maintained in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS). Our NIH3T3 cells sustain deletions of the INK4a locus, but contain the wild-type p53 gene. Cells were transfected with an expression vector by a modi®ed calcium phosphate-DNA precipitation method (Chen and Okayama, 1987) , and selected in medium containing 1 mg/ml of G418 (Geneticin; GIBCO). Each cell clone derived from a single transfected cell was isolated using cloning rings (Iwaki Glass), expanded and tested for HA-tagged p19 ARF expression induced by heavy metal. To induce protein expression from a metalothionine promoter, cells were plated at a low density (about 10% con¯uency), and incubated with 100 mM of ZnSO 4 for the times indicated (48 h in most experiments). The doubling times of NIH3T3 cells in the presence and absence of 100 mM of ZnSO 4 were identical.
For¯ow cytometric analysis of DNA content, cells were suspended in a 1 ml solution of 0.1% sodium citrate and 0.1% Triton X-100 containing 50 mg/ml of propidium iodide and treated with 1 mg/ml of RNase for 30 min at room temperature. Fluorescence from the propidium iodide-DNA complex was measured with a FACScan¯ow cytometer (Becton Dickinson), and the percentages of cells in G1, S, and G2/M phases of the cell cycle were determined.
Antibodies
Rabbit polyclonal antibodies to cyclins A, B1, and E, cdc2, cdk2, cdk4, p21
Cip1
, and p27
Kip1 and mouse monoclonal antibody to cyclin D1 were purchased from Santa Cruz Biotechnology. Mouse monoclonal antibodies to an HA peptide epitope (anti-HA antibody, Clone 12CA5), and to pRb were from Boehringer Mannheim and Pharmingen, respectively. Mouse monoclonal antibody and sheep polyclonal antibody to p53 were purchased from Oncogene Research. Rabbit polyclonal antibodies to cdk6, and cyclins D2 and D3 were provided by Dr CJ Sherr, and mouse monoclonal antibody to MDM2 was a gift from Dr AJ Levine.
Cell lysis, immunoprecipitation, and immunoblotting
Cells were lysed for 30 min on ice in EBC buer (50 mM Tris-HCl, pH 7.5, 120 mM NaCl, 0.5% NP-40, and 1 mM EDTA) containing 5 mg/ml of aprotinin, 1 mM PMSF, 0.1 mM NaF, 0.1 mM NaVO 4 and 1 mM DTT. After clari®cation by centrifugation, lysates extracted from an equal number of cells were incubated with excess amounts of rabbit or mouse antibody for 16 h at 48C. After 1 h incubation with protein A-Sepharose beads (for rabbit antibody) or beads precoated with rabbit antibody to mouse immunoglobulin (for mouse antibody), immunoprecipitates were collected by centrifugation and washed three times with ice-cold EBC buer. Immune complexes were separated on SDS-polyacryamide gels under reducing conditions, transferred to a PVDF (Millipore) or a nitrocellulose (Schleicher and Shuell) membrane, and immunoblotted with the antibodies indicated. When mouse antibody was used as a primary antibody, membranes were treated with rabbit antibody to mouse immunoglobulin. Proteins were detected with the ECL blotting system (Amersham) according to the manufacturer's instructions. Under these conditions, ca 80% of the proteins were quantitatively recovered.
To prepare direct lysates for immunoblotting, cells were lysed in SDS-sample buer (40 mM Tris-HCl, pH 6.8, 0.1 M DTT, 1% SDS, 10% glycerol, and 0.05% Bromophenol Blue) and boiled for 4 min. The cell lysates clari®ed by centrifugation were analysed by immunoblotting as described above. Mouse MDM2 cDNA (a gift from Dr Levine) was transcribed and translated in vitro using the TNT T7/T3 Coupled Reticulocyte Lysate Systems kit (Promega) according to the manufacturer's instructions except that we used unlabeled methionine in lieu of labeled amino acids, as a control in immunoblotting experiments.
Immune complex kinase assay
Cdk2 complexes concentrated by immunoprecipitation using antibody to cdk2 were washed with kinase buer (50 mM HEPES pH 7.5, 10 mM MgCl 2 ) twice and incubated for 15 min at 308C in 25 ml of kinase buer supplemented with 1 mM DTT, phosphatase inhibitors (NaF and NaVO 4 , see above), 5 mg of Histone H1, and 3.3 mCi (0.12 MBq) of [g- For an in vitro kinase assay for cdk4 complexes, cells were lysed in Tween buer (50 mM HEPES, pH 7.5, 150 mM NaCl, 2.5 mM EGTA, 1 mM EDTA, 0.1% Tween-20) containing 5 mg/ml of aprotinin, 1 mM PMSF, 0.1 mM NaF, 0.1 mM NaVO 4 and 1 mM DTT (Matsushime, et al., 1994) , frozen in liquid nitrogen, thawed in ice water and incubated for 1 h on ice. Cdk4 complexes were collected by quantitative immunoprecipitation using an excess amount of antibody to cdk4 as described previously except that Tween buer was used in lieu of EBC buer. Kinase reaction was performed for 30 min at 308C in 30 ml of kinase buer supplemented with 1 mM DTT, phosphatase inhibitors (NaF and NaVO 4 see above), GST-pRb substrates prepared as described (Matsushime et al., 1994) S-LABEL, 1175 Ci/ mmole, ICN) in the same medium. For pulse chase experiments, labeled cells were extensively washed with PBS, and incubated for indicated times in medium containing FBS and 25 mg/ml of cold methionine. The radiolabeled proteins isolated and separated as previousyl described above were analysed and quanti®ed using a Fuji BAS-2000 image analyzer.
